Yujin Jin
Graduate researcher from Sep 2024
BSc. Department of Chemistry, Hankuk University of Foreign Studies
Research interests
Oncology immunotherapy, Antibody-Drug conjugates, Antibody structure optimization
Words
Do as much as you can, know as much as you can.
Google scholar link: https://scholar.google.com/citations?hl=ko&user=sdN53loAAAAJ&scilu=&scisig=ACUpqDcAAAAAaMkAsdL36tfqRzXCwe3nWdLSimo&gmla=AH8HC4zDkMVx-D6J27HFeXh08bytEPjEypoRvd0-eV_DrCxASrODSLnYTrNdK-Nfw2GuCtr-V8ymgSJLoN1DJG7CoImFS9jy7wLH3Ok0sZsqULE0QRdjZETj-kQlKRw1QM4249c&sciund=1362306762500676288
Patent
1. 항-EGFRvIII 항체 및 이를 포함하는 조성물
(이창한, 주민영, 진유진, 홍지수, 강형진)
10-2025-0137254
Publication
1. Dual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition
Advanced Science, 14 January 2026
(Jihui Han, June-Hyun Jeong, Dongjoon Lee, Yujin Jung, Yujin Jin, Sun Sun Jung, Haeng Jun Kim, Woo Youn
Kim, Chang-Han Lee, Inhee Mook-Jung)